Rise Therapeutics LLC
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Rise Therapeutics LLC
RECRUITINGPhase 1NCT06398418
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in...
The goal of this study is determine the safety and tolerability of orally taken probiotic (R-5780) in patients currently on a PD-1 Pathway Checkpoint Inhibitor (checkpoint protein...
Sponsor: Rise Therapeutics LLCEnrolling: 331 location
Solid Tumor, AdultSolid TumorMelanoma+3
RECRUITINGPhase 1NCT05961592
R-2487 in Patients With Rheumatoid Arthritis
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of...
Sponsor: Rise Therapeutics LLCEnrolling: 735 locations
Arthritis, Rheumatoid
RECRUITINGPhase 1NCT05666960
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis. Patients will take an...
Sponsor: Rise Therapeutics LLCEnrolling: 364 locations
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic+1